New Research: 416 Million People at Risk of Developing Alzheimer’s Disease Globally
A new study published by PAVE in Alzheimer's & Dementia: The Journal of the Alzheimer's Association highlights prevalence of Alzheimer’s disease across disease stages. Findings suggest that a majority of patients are asymptomatic or preclinical, and new strategies for the prevention of Alzheimer’s disease could benefit millions of people over the age of 50.
PAVE Research: “Estimates of Current Capacity for Diagnosing Alzheimer’s Disease in Sweden and the Need to Expand Specialist Numbers”
This study assesses Sweden's current capacity to diagnose patients eligible for disease-modifying AD treatment in a timely manner and estimates the investment needed to reduce wait times to a target of less than six months.
